RBC Sees Limited Exposure to Medicaid Risks for Tenet (THC), Reiterated $189 Target

In This Article: Tenet Healthcare Corporation (NYSE:THC) is one of the 20 undervalued momentum stocks that are taking off. On June 11, RBC Capital analyst Ben Hendrix reiterated a Buy rating on Tenet Healthcare (THC), maintaining a price target of $189. The reaffirmation follows recent volatility…